시장보고서

상품코드

1872736

불소-18 시장 규모 및 예측(2021-2031년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 제품 유형별, 용도별, 최종 사용자별, 지역별

Fluorine-18 Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Geography

발행일: 2025년 10월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 200 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당사의 새로운 조사 연구 「불소-18 시장 규모 및 예측(2021-2031년)」에 의하면, 시장 규모는 2024년의 18억 5,000만 달러로 평가되었고 2031년까지 25억 3,000만 달러로 성장할 것으로 예측되고 있습니다. 2025-2031년의 CAGR은 4.7%를 나타낼 전망입니다. 불소-18 시장의 성장은 암 유병률 증가, PET 영상 검사 확대, PET 스캐너 및 영상 시스템 기술 발전, 규제 승인 및 신형 불소-18 트레이서 개발 등에 기인합니다.

불소-18(F-18)은 방사성 불안정 불소 동위원소로, 양전자 방출 단층 촬영(PET) 영상에서 트레이서로 주요 활용됩니다. 이는 영상화를 통해 신체의 대사 및 생화학적 활동 시각화를 가능하게 하여 암 진단 및 뇌 연구 등에 매우 유용합니다.

북미의 불소-18 시장은 미국, 캐나다, 멕시코로 세분화됩니다. 북미 불소-18 시장은 여러 요인으로 인해 확장되고 있습니다. 미국이 가장 큰 시장 점유율을 차지하며 캐나다가 그 뒤를 잇습니다. 이 지역의 불소-18 수요는 선진적인 핵의학 인프라에 힘입어 증가하고 있으며, 전 세계 1,200여 대의 사이클로트론 중 약 75%가 미국과 캐나다에 집중되어 있고 멕시코에서도 성장이 나타나고 있습니다.

미국은 전 세계 1,200개 이상의 사이클로트론으로 구성된 강력한 인프라를 바탕으로 양전자 방출 단층 촬영(PET) 영상용 2-[18F]플루오로-2-데옥시-D-글루코스(FDG)와 같은 불소-18 기반 방사성 트레이서(radiotracer)의 광범위한 생산을 가능케 하여 북미 불소-18 시장을 주도하고 있습니다. 이 동위원소의 110분 반감기는 MD 앤더슨 암 센터의 사이클로트론 및 방사화학 프로그램과 같은 주요 시설의 현장 합성을 지원하여, 주로 폐암 및 대장암(8%)과 같은 암의 과대사 활동을 탐지하는 종양학 분야에서 연간 250만 건 이상의 PET 스캔에 대한 적시 공급을 보장합니다. 미국 암 학회(American Cancer Society)는 2025년에 230만 건의 새로운 암 진단이 있을 것으로 예상하며, FDG-PET/CT가 전이 감지 민감도 90% 이상으로 병기 분류를 정밀화하고 불필요한 수술을 방지함으로써 38%의 사례에서 치료 관리를 변화시키면서 수요를 증폭시키고 있습니다. 신경학 분야 적용도 급증 중입니다. 670만 알츠하이머 환자군에서 플로르베타피르(2012년 승인) 같은 아밀로이드 추적제는 90-95% 정확도로 플라크를 시각화하며, 경도인지장애 사례의 60%에서 알츠하이머를 다른 치매와 구분합니다. 심장학 분야에서는 2024년 9월 FDA의 플루르피리다즈 F-18(플라이르카도) 승인이 이정표가 되었으며, 관상동맥질환 검출 정확도 87%를 제공하여 SPECT와 경쟁하면서 검사 시간을 30% 단축시켜 연간 100만 건의 심근 생존성 평가를 수행할 준비가 되어 있습니다. 또한 2020년 이후 40개 이상의 신규 불소-18 화합물이 임상시험 중이며, 메디케어가 PET 청구액의 80%를 보장하는 규제적 추진력이 FDG 1회 투여당 300-500달러의 비용에도 불구하고 성장을 촉진하고 있습니다. 신규 설치 장비의 70%에 적용된 비행시간 PET/CT와 같은 혁신 기술은 신호대잡음비를 40% 향상시켜 더 낮은 선량 사용을 가능하게 합니다. 고령화 인구 증가로 핵의학 검사가 필요한 성인 1억 명 이상이 발생함에 따라, 소형 사이클로트론을 통한 분산 생산은 농촌 지역 부족 현상을 해결하여 2030년까지 시술량을 15-20% 증가시킬 잠재력을 지닙니다. 2024년 동위원소 시설에 대한 3,200만 달러 규모의 미국 에너지부(DOE) 보조금으로 강화된 이 생태계는 미국을 불소-18 강국으로 자리매김시켜 정밀 진단을 향상시키고 조기 개입을 통한 암 사망률을 감소시킵니다.

미래 시장 기회를 제공하기 위한 불소-18 영상 분석에 인공지능 통합

인공 지능(AI)을 불소-18 기반 양전자 방출 단층 촬영(PET) 영상 분석에 통합함으로써 진단 정확도를 높이고 임상 워크플로우를 간소화하여 시장에 혁신을 가져올 준비가 되어 있습니다. AI 알고리즘, 특히 딥 러닝 모델은 2-[18F]플루오로-2-데옥시-D-글루코스(FDG)와 같은 불소-18 트레이서 흡수 패턴을 해석하는 데 점점 더 많이 적용되어, 인간 판독자에 비해 종양 병변을 90-95%의 정확도로 감지합니다. 2040년까지 전 세계적으로 2천만 건의 신규 암 사례가 발생할 것으로 예상되는 종양학 분야에서, AI 기반 FDG-PET/CT 스캔 분석은 폐암 전이를 92%의 민감도로 식별하여 위음성률을 20% 감소시킵니다. 신경학 분야에서는 AI가 플로르베타피르를 활용해 알츠하이머병의 아밀로이드 플라크 부하를 정량화하며, 2025년 5,500만 치매 환자군에서 90% 정확도로 질병 진행을 예측합니다. 해당 모델은 표준 흡수값(SUV) 계산도 최적화하여 분석 시간을 30% 단축하고 실시간 의사결정을 가능케 합니다. 전립선암 분야에서 AI 강화 18F-DCFPyL PET/CT 분석은 수동 판독 시 15%에서 놓친 잠복 병변을 발주도하여 40% 사례에서 치료 계획을 변경시켰습니다. 영상 진단 분야 AI의 글로벌 도입이 가속화되며, PET/CT 설치량이 연간 15% 증가함에 따라 2025년까지 미국 및 유럽 PET 센터의 25%가 해당 도구를 통합할 전망입니다. 150대의 사이클로트론과 5억 달러 규모의 핵의학 투자를 보유한 인도 같은 개발도상국들은 오픈소스 AI 플랫폼을 활용해 전문성 격차를 해소하고 있으며, 이로 인해 진단 접근성이 20% 증가할 가능성이 있습니다. AI는 또한 테라노스틱스를 지원하여 전립선암에서 루테튬-177-PSMA 치료에 대한 반응을 85% 정확도로 예측함으로써 생존 기간을 12개월 연장합니다. 2024년 SNMMI AI 태스크포스 같은 이니셔티브는 프로토콜을 조화시켜 도입을 촉진하는 것을 목표로 합니다. 이러한 추세는 특히 부담이 큰 질환에서 불소-18 시술량을 증가시키고, 진단 비용을 절감하며, 정밀 의학을 향상시켜 자동화되고 확장 가능한 영상 솔루션으로의 시장 전환을 촉진할 수 있습니다.

불소-18 시장 보고서 작성에 있어서 미국 식품의약품국(FDA), 국제암연구기관(IARC), 세계은행 데이터, 영국 국민보건서비스(NHS), 유럽의약품청(EMA), 세계보건기구(WHO) 등이 1차 조사와 2차 조사로 참조되었습니다.

불소-18 시장 : 주요 시장 역학
시장 성장 촉진요인
- 암 유병률 증가로 인한 PET 영상 검사 확대
- PET 스캐너 및 영상 시스템의 기술 발전
- 신규 불소-18 트레이서 규제 승인 및 개발
시장 성장 억제요인
- 제한된 사이클로트론 가용성 및 생산 제약
- 불소-18의 유통의 높은 운영 및 물류 비용
- 불소-18 트레이서에 대한 보험급여 및 규제 과제
시장 기회
- 불소-18 트레이서를 활용한 치료진단(Theranostic) 응용 분야 확대
- 불소-18 트레이서의 신경학 분야 응용 성장
- 자동화 합성 및 생산 기술 발전
향후의 동향
- 불소-18 영상 분석에 인공지능(AI) 통합
- 새로운 용도용 신규 불소-18 트레이서 개발
- 모바일 및 분산형 PET 영상 솔루션 확대
성장 촉진요인과 억제요인의 영향

제6장 불소-18 시장 : 세계 시장 분석

불소-18 시장 수익(2021-2031년)
불소-18 시장 예측 분석

제7장 불소-18 시장 분석 : 제품 유형별

FDG
NaF
기타

제8장 불소-18 시장 분석 : 용도별

종양학
심장병학
신경학
기타

제9장 불소-18 시장 분석 : 최종 사용자별

병원
진단 및 영상 센터
기타

제10장 불소18 시장 : 지역별

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
중동 및 아프리카
- 사우디아라비아
- 남아프리카
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제11장 경쟁 구도

주요 기업별 히트맵 분석
기업별 시장 점유율 분석(2024년)

제12장 업계 정세

시장 이니셔티브
합병 및 인수

제13장 기업 프로파일

제14장 부록

HBR 25.12.11

According to our new research study on "Fluorine 18 Market Forecast to 2031 -Global Analysis - by Treatment Type, Disease Type, and End User," the market is anticipated to grow from US$ 1.85 billion in 2024 to US$ 2.53 billion by 2031; the market is expected to register a CAGR of 4.7% from 2025 to 2031. The fluorine 18 market growth are attributed to the rising prevalence of cancers, increasing pet imaging, technological advancements in PET scanners and imaging systems, and regulatory approvals and development of novel fluorine-18 tracers.

Fluorine-18 (F-18) is a radioactively unstable fluorine isotope that finds major applications as a tracer in positron emission tomography (PET) imaging. It facilitates the visualization of the body's metabolic and biochemical activities through imaging, which is very helpful in cancer diagnosis and brain research, among other things..

The fluorine 18 market in North America is segmented into the US, Canada, and Mexico. The North America fluorine 18 market is expanding owing to several factors. The US holds the largest market share, followed by Canada. The demand for fluorine 18 in the region is fueled by the advanced nuclear medicine infrastructure, with approximately 75% of the world's 1,200 cyclotrons concentrated in the US and Canada, and emerging growth in Mexico.

The US dominates the North American Fluorine-18 market, driven by a robust infrastructure of over 1,200 cyclotrons globally, enabling widespread production of Fluorine-18-based radiotracers such as 2-[18F]fluoro-2-deoxy-D-glucose (FDG) for positron emission tomography (PET) imaging. This isotope's 110-minute half-life supports on-site synthesis in major facilities such as the MD Anderson Cancer Center's Cyclotron and Radiochemistry Program, ensuring timely distribution for over 2.5 million annual PET scans, predominantly in oncology where it detects hypermetabolic activity in cancers like lung and colorectal (8%). The American Cancer Society projects 2.3 million new cancer diagnoses in 2025, amplifying demand as FDG-PET/CT alters management in 38% of cases by refining staging and averting unnecessary surgeries, with sensitivity exceeding 90% for metastases. Neurological applications are surging amid 6.7 million Alzheimer's patients, where amyloid tracers like florbetapir (approved 2012) visualize plaques with 90-95% accuracy, distinguishing Alzheimer's from other dementias in 60% of mild cognitive impairment cases. In cardiology, the FDA's September 2024 approval of flurpiridaz F-18 (Flyrcado) marks a milestone, offering 87% accuracy in coronary artery disease detection, rivaling SPECT while reducing scan times by 30%, poised to serve 1 million annual myocardial viability assessments. Additionally, regulatory momentum, with over 40 novel Fluorine-18 compounds in trials since 2020, and Medicare covering 80% of PET claims, fuels growth despite costs of US$ 300-US$ 500 per FDG dose. Innovations such as time-of-flight PET/CT in 70% of new installations boost signal-to-noise ratios by 40%, enabling lower doses. As aging population increases over 100 million adults needing nuclear scans decentralized production via mini-cyclotrons addresses rural shortages, potentially increasing procedural volumes by 15-20% by 2030. This ecosystem, bolstered by US$ 32 million DOE grants in 2024 for isotope facilities, positions the US as a Fluorine-18 powerhouse, enhancing precision diagnostics and reducing cancer mortality through early interventions

Integration of Artificial Intelligence in Fluorine-18 Imaging Analysis to Provide Market Opportunities in Future

The integration of artificial intelligence (AI) into Fluorine-18-based positron emission tomography (PET) imaging analysis is poised to revolutionize the market by enhancing diagnostic accuracy and streamlining clinical workflows. AI algorithms, particularly deep learning models, are increasingly applied to interpret Fluorine-18 tracer uptake patterns, such as those of 2-[18F]fluoro-2-deoxy-D-glucose (FDG), achieving 90-95% accuracy in detecting oncologic lesions compared to human readers. In oncology, where 20 million new cancer cases are projected globally by 2040, AI-driven analysis of FDG-PET/CT scans identifies metastases in lung cancer with 92% sensitivity, reducing false negatives by 20%. For neurological applications, AI quantifies amyloid plaque burden in Alzheimer's using florbetapir, predicting disease progression with 90% accuracy across 55 million dementia cases in 2025. These models also optimize standardized uptake value (SUV) calculations, cutting analysis time by 30% and enabling real-time decision-making. In prostate cancer, AI-enhanced 18F-DCFPyL PET/CT analysis has altered treatment plans in 40% of cases by detecting occult lesions missed in 15% of manual interpretations. The global adoption of AI in imaging is accelerating, with 25% of PET centers in the US and Europe integrating such tools by 2025, driven by a 15% annual increase in PET/CT installations. Developing countries such as India, with 150 cyclotrons and US$ 500 million in nuclear medicine investments, are leveraging open-source AI platforms to bridge expertise gaps, potentially increasing diagnostic access by 20%. AI also supports theranostics, predicting response to Lutetium-177-PSMA therapy in prostate cancer with 85% accuracy, improving survival by 12 months. The initiatives such as the 2024 SNMMI AI Task Force aim to harmonize protocols, boosting adoption. This trend could increase Fluorine-18 procedural volumes, reduce diagnostic costs, and enhance precision medicine, particularly in high-burden diseases, fostering a market shift toward automated, scalable imaging solutions.

The US Food and Drug Administration, International Agency for Research on Cancer (IARC), World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization) are among the primary and secondary sources referred to while preparing the fluorine 18 market report.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Fluorine-18 Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Fluorine-18 Market - Key Market Dynamics

5.1 Fluorine-18 Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Cancers Increasing PET Imaging
- 5.2.2 Technological Advancements in PET Scanners and Imaging Systems
- 5.2.3 Regulatory Approvals and Development of Novel Fluorine-18 Tracers
5.3 Market Restraints
- 5.3.1 Limited Cyclotron Availability and Production Constraints
- 5.3.2 High Operational and Logistical Costs of Fluorine-18 Distribution
- 5.3.3 Reimbursement and Regulatory Challenges for Fluorine-18 Tracers
5.4 Market Opportunities
- 5.4.1 Expansion of Theranostic Applications with Fluorine-18 Tracers
- 5.4.2 Growth in Neurological Applications for Fluorine-18 Tracers
- 5.4.3 Advancements in Automated Synthesis and Production Technologies
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence in Fluorine-18 Imaging Analysis
- 5.5.2 Development of Novel Fluorine-18 Tracers for Emerging Applications
- 5.5.3 Expansion of Mobile and Decentralized PET Imaging Solutions
5.6 Impact of Drivers and Restraints:

6. Fluorine-18 Market - Global Market Analysis

6.1 Fluorine-18 Market Revenue (US$ Million), 2021-2031
6.2 Fluorine-18 Market Forecast Analysis

7. Fluorine-18 Market Analysis - by Product Type

7.1 FDG
- 7.1.1 Overview
- 7.1.2 FDG: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
7.2 NaF
- 7.2.1 Overview
- 7.2.2 NaF: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Others
- 7.3.1 Overview
- 7.3.2 Others: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)

8. Fluorine-18 Market Analysis - by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Cardiology
- 8.2.1 Overview
- 8.2.2 Cardiology: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Neurology
- 8.3.1 Overview
- 8.3.2 Neurology: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)

9. Fluorine-18 Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostic and Imaging Centers
- 9.2.1 Overview
- 9.2.2 Diagnostic and Imaging Centers: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Fluorine-18 Market - Revenue and Forecast to 2031 (US$ Million)

10. Fluorine-18 Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Fluorine-18 Market Overview
- 10.2.2 North America: Fluorine-18 Market - Revenue, 2021-2031 (US$ Million)
- 10.2.3 North America: Fluorine-18 Market Breakdown, by Product Type
  - 10.2.3.1 North America: Fluorine-18 Market - Revenue and Forecast Analysis - by Product Type
- 10.2.4 North America: Fluorine-18 Market Breakdown, by Application
  - 10.2.4.1 North America: Fluorine-18 Market - Revenue and Forecast Analysis - by Application
- 10.2.5 North America: Fluorine-18 Market Breakdown, by End User
  - 10.2.5.1 North America: Fluorine-18 Market - Revenue and Forecast Analysis - by End User
- 10.2.6 North America: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.2.6.1 North America: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.2.6.2 United States: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.6.2.1 United States: Fluorine-18 Market Breakdown, by Product Type
    - 10.2.6.2.2 United States: Fluorine-18 Market Breakdown, by Application
    - 10.2.6.2.3 United States: Fluorine-18 Market Breakdown, by End User
  - 10.2.6.3 Canada: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.6.3.1 Canada: Fluorine-18 Market Breakdown, by Product Type
    - 10.2.6.3.2 Canada: Fluorine-18 Market Breakdown, by Application
    - 10.2.6.3.3 Canada: Fluorine-18 Market Breakdown, by End User
  - 10.2.6.4 Mexico: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.6.4.1 Mexico: Fluorine-18 Market Breakdown, by Product Type
    - 10.2.6.4.2 Mexico: Fluorine-18 Market Breakdown, by Application
    - 10.2.6.4.3 Mexico: Fluorine-18 Market Breakdown, by End User
10.3 Europe
- 10.3.1 Europe Fluorine-18 Market Overview
- 10.3.2 Europe: Fluorine-18 Market - Revenue, 2021-2031 (US$ Million)
- 10.3.3 Europe: Fluorine-18 Market Breakdown, by Product Type
  - 10.3.3.1 Europe: Fluorine-18 Market - Revenue and Forecast Analysis - by Product Type
- 10.3.4 Europe: Fluorine-18 Market Breakdown, by Application
  - 10.3.4.1 Europe: Fluorine-18 Market - Revenue and Forecast Analysis - by Application
- 10.3.5 Europe: Fluorine-18 Market Breakdown, by End User
  - 10.3.5.1 Europe: Fluorine-18 Market - Revenue and Forecast Analysis - by End User
- 10.3.6 Europe: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.3.6.1 Europe: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.3.6.2 Germany: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.6.2.1 Germany: Fluorine-18 Market Breakdown, by Product Type
    - 10.3.6.2.2 Germany: Fluorine-18 Market Breakdown, by Application
    - 10.3.6.2.3 Germany: Fluorine-18 Market Breakdown, by End User
  - 10.3.6.3 United Kingdom: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.6.3.1 United Kingdom: Fluorine-18 Market Breakdown, by Product Type
    - 10.3.6.3.2 United Kingdom: Fluorine-18 Market Breakdown, by Application
    - 10.3.6.3.3 United Kingdom: Fluorine-18 Market Breakdown, by End User
  - 10.3.6.4 France: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.6.4.1 France: Fluorine-18 Market Breakdown, by Product Type
    - 10.3.6.4.2 France: Fluorine-18 Market Breakdown, by Application
    - 10.3.6.4.3 France: Fluorine-18 Market Breakdown, by End User
  - 10.3.6.5 Italy: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.6.5.1 Italy: Fluorine-18 Market Breakdown, by Product Type
    - 10.3.6.5.2 Italy: Fluorine-18 Market Breakdown, by Application
    - 10.3.6.5.3 Italy: Fluorine-18 Market Breakdown, by End User
  - 10.3.6.6 Spain: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.6.6.1 Spain: Fluorine-18 Market Breakdown, by Product Type
    - 10.3.6.6.2 Spain: Fluorine-18 Market Breakdown, by Application
    - 10.3.6.6.3 Spain: Fluorine-18 Market Breakdown, by End User
  - 10.3.6.7 Rest of Europe: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.6.7.1 Rest of Europe: Fluorine-18 Market Breakdown, by Product Type
    - 10.3.6.7.2 Rest of Europe: Fluorine-18 Market Breakdown, by Application
    - 10.3.6.7.3 Rest of Europe: Fluorine-18 Market Breakdown, by End User
10.4 Asia Pacific
- 10.4.1 Asia Pacific Fluorine-18 Market Overview
- 10.4.2 Asia Pacific: Fluorine-18 Market - Revenue, 2021-2031 (US$ Million)
- 10.4.3 Asia Pacific: Fluorine-18 Market Breakdown, by Product Type
  - 10.4.3.1 Asia Pacific: Fluorine-18 Market - Revenue and Forecast Analysis - by Product Type
- 10.4.4 Asia Pacific: Fluorine-18 Market Breakdown, by Application
  - 10.4.4.1 Asia Pacific: Fluorine-18 Market - Revenue and Forecast Analysis - by Application
- 10.4.5 Asia Pacific: Fluorine-18 Market Breakdown, by End User
  - 10.4.5.1 Asia Pacific: Fluorine-18 Market - Revenue and Forecast Analysis - by End User
- 10.4.6 Asia Pacific: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.4.6.1 Asia Pacific: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.4.6.2 China: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.6.2.1 China: Fluorine-18 Market Breakdown, by Product Type
    - 10.4.6.2.2 China: Fluorine-18 Market Breakdown, by Application
    - 10.4.6.2.3 China: Fluorine-18 Market Breakdown, by End User
  - 10.4.6.3 Japan: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.6.3.1 Japan: Fluorine-18 Market Breakdown, by Product Type
    - 10.4.6.3.2 Japan: Fluorine-18 Market Breakdown, by Application
    - 10.4.6.3.3 Japan: Fluorine-18 Market Breakdown, by End User
  - 10.4.6.4 India: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.6.4.1 India: Fluorine-18 Market Breakdown, by Product Type
    - 10.4.6.4.2 India: Fluorine-18 Market Breakdown, by Application
    - 10.4.6.4.3 India: Fluorine-18 Market Breakdown, by End User
  - 10.4.6.5 Australia: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.6.5.1 Australia: Fluorine-18 Market Breakdown, by Product Type
    - 10.4.6.5.2 Australia: Fluorine-18 Market Breakdown, by Application
    - 10.4.6.5.3 Australia: Fluorine-18 Market Breakdown, by End User
  - 10.4.6.6 South Korea: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.6.6.1 South Korea: Fluorine-18 Market Breakdown, by Product Type
    - 10.4.6.6.2 South Korea: Fluorine-18 Market Breakdown, by Application
    - 10.4.6.6.3 South Korea: Fluorine-18 Market Breakdown, by End User
  - 10.4.6.7 Rest of APAC: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.6.7.1 Rest of APAC: Fluorine-18 Market Breakdown, by Product Type
    - 10.4.6.7.2 Rest of APAC: Fluorine-18 Market Breakdown, by Application
    - 10.4.6.7.3 Rest of APAC: Fluorine-18 Market Breakdown, by End User
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Fluorine-18 Market Overview
- 10.5.2 Middle East and Africa: Fluorine-18 Market - Revenue, 2021-2031 (US$ Million)
- 10.5.3 Middle East and Africa: Fluorine-18 Market Breakdown, by Product Type
  - 10.5.3.1 Middle East and Africa: Fluorine-18 Market - Revenue and Forecast Analysis - by Product Type
- 10.5.4 Middle East and Africa: Fluorine-18 Market Breakdown, by Application
  - 10.5.4.1 Middle East and Africa: Fluorine-18 Market - Revenue and Forecast Analysis - by Application
- 10.5.5 Middle East and Africa: Fluorine-18 Market Breakdown, by End User
  - 10.5.5.1 Middle East and Africa: Fluorine-18 Market - Revenue and Forecast Analysis - by End User
- 10.5.6 Middle East and Africa: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.5.6.1 Middle East and Africa: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.5.6.2 Saudi Arabia: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.6.2.1 Saudi Arabia: Fluorine-18 Market Breakdown, by Product Type
    - 10.5.6.2.2 Saudi Arabia: Fluorine-18 Market Breakdown, by Application
    - 10.5.6.2.3 Saudi Arabia: Fluorine-18 Market Breakdown, by End User
  - 10.5.6.3 South Africa: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.6.3.1 South Africa: Fluorine-18 Market Breakdown, by Product Type
    - 10.5.6.3.2 South Africa: Fluorine-18 Market Breakdown, by Application
    - 10.5.6.3.3 South Africa: Fluorine-18 Market Breakdown, by End User
  - 10.5.6.4 United Arab Emirates: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.6.4.1 United Arab Emirates: Fluorine-18 Market Breakdown, by Product Type
    - 10.5.6.4.2 United Arab Emirates: Fluorine-18 Market Breakdown, by Application
    - 10.5.6.4.3 United Arab Emirates: Fluorine-18 Market Breakdown, by End User
  - 10.5.6.5 Rest of Middle East and Africa: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.6.5.1 Rest of Middle East and Africa: Fluorine-18 Market Breakdown, by Product Type
    - 10.5.6.5.2 Rest of Middle East and Africa: Fluorine-18 Market Breakdown, by Application
    - 10.5.6.5.3 Rest of Middle East and Africa: Fluorine-18 Market Breakdown, by End User
10.6 South and Central America
- 10.6.1 South and Central America Fluorine-18 Market Overview
- 10.6.2 South and Central America: Fluorine-18 Market - Revenue, 2021-2031 (US$ Million)
- 10.6.3 South and Central America: Fluorine-18 Market Breakdown, by Product Type
  - 10.6.3.1 South and Central America: Fluorine-18 Market - Revenue and Forecast Analysis - by Product Type
- 10.6.4 South and Central America: Fluorine-18 Market Breakdown, by Application
  - 10.6.4.1 South and Central America: Fluorine-18 Market - Revenue and Forecast Analysis - by Application
- 10.6.5 South and Central America: Fluorine-18 Market Breakdown, by End User
  - 10.6.5.1 South and Central America: Fluorine-18 Market - Revenue and Forecast Analysis - by End User
- 10.6.6 South and Central America: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.6.6.1 South and Central America: Fluorine-18 Market - Revenue and Forecast Analysis - by Country
  - 10.6.6.2 Brazil: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.6.6.2.1 Brazil: Fluorine-18 Market Breakdown, by Product Type
    - 10.6.6.2.2 Brazil: Fluorine-18 Market Breakdown, by Application
    - 10.6.6.2.3 Brazil: Fluorine-18 Market Breakdown, by End User
  - 10.6.6.3 Argentina: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.6.6.3.1 Argentina: Fluorine-18 Market Breakdown, by Product Type
    - 10.6.6.3.2 Argentina: Fluorine-18 Market Breakdown, by Application
    - 10.6.6.3.3 Argentina: Fluorine-18 Market Breakdown, by End User
  - 10.6.6.4 Rest of South and Central America: Fluorine-18 Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.6.6.4.1 Rest of South and Central America: Fluorine-18 Market Breakdown, by Product Type
    - 10.6.6.4.2 Rest of South and Central America: Fluorine-18 Market Breakdown, by Application
    - 10.6.6.4.3 Rest of South and Central America: Fluorine-18 Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Merger and Acquisition

13. Company Profiles

13.1 Company Name
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

14. Appendix

14.1 About The Insight Partners